DSIP 10mg Dosage Protocol | PeptideDosages.com

For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

DSIP (10 mg Vial) Dosage Protocol

DSIP Dosage Chart

DSIP (Delta Sleep-Inducing Peptide) is dosed at 100 mcg–300 mcg daily via subcutaneous injection in educational protocols, usually before bedtime. A 10 mg vial reconstituted with bacteriostatic water yields about 3.33 mg/mL. This information is for research and educational use only.

Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.

Typical daily range: 100–300 mcg once daily in the evening (gradual titration).

Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

DSIP dosage protocols can help promote deep, restorative delta-wave sleep and support healthy stress response. Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (9 amino acids) first isolated from rabbit brain for its ability to enhance slow-wave sleep[1]. Research indicates DSIP may improve sleep quality, normalize sleep architecture, reduce stress-related cortisol patterns, and support mood stabilization without next-day grogginess[2][3]. This educational protocol presents a once-daily subcutaneous evening approach using a practical dilution for clear insulin-syringe measurements.

Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read DSIP Peptide: Benefits, Uses, Side Effects, Dosage, and Research.

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Week 1

100 mcg

3 units (0.03 mL)

Week 2

150 mcg

5 units (0.05 mL)

Week 3

200 mcg

6 units (0.06 mL)

Weeks 4–8

250–300 mcg

8–9 units (0.08–0.09 mL)

Frequency: Inject once daily subcutaneously in the evening, approximately 30–60 minutes before bedtime[4]. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved (do not shake).

Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Supplies Needed

Plan based on an 8–12 week nightly protocol with gradual titration.

Peptide Vials (DSIP, 10 mg each):

8 weeks ≈ 1 vial (10 mg supports ~33–100 doses at 100–300 mcg)

12 weeks ≈ 2 vials

Insulin Syringes (30- or 50-unit recommended for small volumes):

Per week: 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.

8 weeks (1 vial): 3 mL → 1 × 10 mL bottle

12 weeks (2 vials): 6 mL → 1 × 10 mL bottle

Alcohol Swabs: One for the vial stopper + one for the injection site each day.

Per week: 14 swabs (2/day)

8 weeks: 112 swabs → recommend 2 × 100-count boxes

12 weeks: 168 swabs → recommend 2 × 100-count boxes

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Retinalamin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Retinalamin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗

02VK2735 — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. VK2735 is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗

03Amycretin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Amycretin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗

04AHK-Cu — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 50 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 50 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. AHK-Cu is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗

05Teduglutide — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Teduglutide is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗

Research context

Read sources and limitations before applying a claim.

The Mechanism That Frames Every Research Question

Every legitimate research question about Sermorelin ultimately traces back to its mechanism, so it is worth laying that out precisely. Sermorelin binds the GHRH receptor (GHRHR), a class B G-protein-coupled receptor expressed predominantly on the somatotroph cells of the anterior pituitary. Receptor engagement activates the stimulatory Gs protein, which stimulates adenylyl cyclase, raising intracellular cyclic AMP. The rise in cAMP activates protein kinase A, which both promotes the immediate release of stored growth hormone and, through downstream transcription factors such as CREB and the pituitary-specific factor Pit-1, drives transcription of the GH gene and supports somatotroph proliferation.6 In short, Sermorelin does not supply growth hormone; it instructs the pituitary to make and release its own. The mechanics of that pituitary-level signaling are explored further in the site’s discussion of how Sermorelin affects pituitary signaling in endocrine research. Two features of this mechanism generate most of the compound’s theoretical appeal, and both deserve careful, non-inflated treatment. The first is preservation of feedback. Growth-hormone secretion is restrained by somatostatin, the hypothalamic “off” signal, and by IGF-1-mediated negative feedback. Because Sermorelin acts upstream at the pituitary rather than flooding the body with exogenous hormone, its output remains subject to these brakes. The practical implication, argued in the clinical literature, is that it is difficult to drive endogenous GH to grossly supraphysiological levels with a GHRH stimulus alone, because somatostatin tone rises to oppose it.4 This is a genuine and attractive property in principle — it is the mechanistic basis for the claim that GHRH-based approaches are “self-limiting” in a way that injected recombinant GH is not. The second is pulsatility. Physiological GH secretion is episodic, occurring in discrete pulses (especially during slow-wave sleep) against a low baseline. This pulsatile pattern is not incidental; the biological effects of GH depend partly on the pattern of exposure, not merely the total amount. A GHRH stimulus, working through the intact pituitary, tends to produce release that is more episodic than the flat, non-physiological profile of a recombinant GH injection.4 Restoring a more natural secretory rhythm, rather than simply raising the average, is one of the more scientifically interesting propositions attached to the compound. Here honesty requires a firm caveat. These are compelling mechanistic rationales, and they are frequently presented as though they were demonstrated clinical outcomes. They are not the same thing. That a GHRH analog preserves feedback and encourages pulsatility is a reasonable pharmacological expectation; that this translates into meaningful, durable benefit for body composition, sleep, recovery, or aging in otherwise-healthy adults is a separate empirical question that Sermorelin’s own evidence base does not robustly answer. The mechanism is the source of the hypotheses, not the confirmation of them. And the short half-life re-enters here: a molecule cleared within roughly ten to twelve minutes must be dosed to catch the physiological windows in which it can actually shape a pulse, which is why the timing conventions around it exist and why sustained effects cannot be assumed from a transient signal.3

Source: dosagepeptide.com ↗

Handling and Reconstitution in a Research Context

Because AOD-9604 is most often encountered as a lyophilized (freeze-dried) powder in a sealed vial, a brief, strictly educational note on laboratory handling is warranted — with the emphasis that this is standard research-peptide practice, not a usage recommendation, and that AOD-9604 is not an approved therapeutic for any indication. Lyophilized peptides are generally reconstituted with sterile or bacteriostatic water for laboratory purposes. The diluent is directed slowly against the inside wall of the vial rather than sprayed onto the powder, and the vial is gently swirled rather than shaken, because vigorous agitation can shear peptide bonds and denature the material. The volume of diluent chosen simply sets the concentration: a fixed mass of peptide dissolved in a larger volume yields a lower concentration per unit volume, the arithmetic underlying any reconstitution chart. Standard stability and storage considerations recur across the research-peptide literature. Lyophilized storage Cool, dark conditions; long-term stability favored by freezing After reconstitution Refrigerated; used within a limited window Light and heat Minimize exposure; both can degrade peptides Agitation Swirl gently; avoid shaking or foaming Freeze-thaw Repeated cycles degrade peptides; avoid Sterility Aseptic technique; bacteriostatic water for multi-use practice It bears repeating that meticulous handling changes nothing about the evidence question. A perfectly reconstituted, high-purity vial of AOD-9604 is still a compound whose antilipogenic action is documented only preclinically and never quantified in humans. Good technique preserves whatever biological activity the molecule has; it does not create efficacy where none has been demonstrated. Researchers surveying how these compounds are cataloged can consult the site’s central dosages index, organized for educational reference rather than as guidance for human use.

Source: dosagepeptide.com ↗

Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Vilon Dosage Chart

Vilon is dosed at 67 mcg–667 mcg daily via subcutaneous injection in educational protocols. A 20 mg vial reconstituted with bacteriostatic water yields about 6.67 mg/mL. This information is for research and educational use only. Reconstitute: Add 3.0 mL bacteriostatic water → ~6.67 mg/mL concentration. Typical range: 67–670 mcg once daily for 5 consecutive days per cycle. Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U‑100 insulin syringe. Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); use within 1 week or aliquot and freeze. Vilon (Lys‑Glu) is a synthetic immunoregulatory dipeptide consisting of lysine and glutamic acid residues[1]. Preclinical research indicates it may enhance immune markers including CD5+ lymphocytes and interleukin‑2 expression in thymic and splenic cell cultures[2][3]. This educational protocol presents a pulsed subcutaneous approach (5 consecutive days per 4‑week cycle) using a practical dilution for clear insulin‑syringe measurements. Related research: For distinct compound, component, or formulation evidence and safety context, read Epithalon Peptide: Benefits, Uses, Side Effects, Dosage, and Research. These links are comparisons only; the compounds and formulations should not be treated as interchangeable.

Source: peptidedosages.com ↗

Potential benefits

Potential Benefits & Side Effects

Observations from preclinical and early research literature. May support reductions in fat mass while preserving lean muscle in animal models[5][6]. Associated with elevated NAD+ levels and SIRT1 activation in preclinical studies[2][3]. Enhanced grip strength observed in aged mice when combined with exercise[7]. Generally well tolerated; occasional reports of mild headache, transient jitteriness, or injection-site reactions. Long-term human safety data not established; this compound remains investigational.

Source: peptidedosages.com ↗

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

DSIP (10 mg Vial) Dosage Protocol

DSIP Dosage Chart

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Reconstitution Steps

Supplies Needed

Related questions

The Mechanism That Frames Every Research Question

Handling and Reconstitution in a Research Context

Vilon Dosage Chart

Potential Benefits & Side Effects

Peptide Therapy Guide Editorial Team

Vilon Dosage Protocol | PeptideDosages.com

Vesugen Dosage Protocol | PeptideDosages.com

Testagen Dosage Protocol | PeptideDosages.com

SS-31 30mg Dosage Protocol | PeptideDosages.com